Founded in 2022, Auxilium Health is pioneering a new class of advanced biomaterials designed to accelerate skin tissue regeneration and improve infection management. With over 6.5 million people in the U.S. affected by non-healing wounds-resulting in healthcare costs exceeding $50 billion annually-Auxilium's innovative technology directly addresses this critical and growing medical need. Developed from groundbreaking polymer research led by Chief Technology Officer, Dr. Aparna Agrawal, at the University of Akron, the biomaterial platform has already attracted national and international interest from the healthcare and biotechnology sectors. This early traction reflects a growing belief in the technology's potential, positioning the company to rapidly advance partnerships and product development, which will translate into clinical impac
